Nanjing Pharmaceutical announced that Fujian Tongchun, a subsidiary of the company, plans to invest in the construction of Fujian Tongchun Biopharmaceutical Industry Park (phase I), with a total investment of about 471.6 million yuan.
The chairman of the company is Zhou Jianjun. Mr. Zhou Jianjun: born in 1966, college degree, once served as deputy general manager and general manager of Nanjing Pharmaceutical Co., Ltd.; general manager and chairman of Nanjing Pharmaceutical Services Co., Ltd.; sales Director, General Manager of Pharmaceutical Logistics Center, Pharmaceutical Branch Manager, Major customer Business Director, General Manager of supply chain Service Department of Medical institutions, Vice President, Director, Vice Chairman, President of Nanjing Pharmaceutical Co., Ltd. The current chairman of the company.
This article is compiled by the Securities Star data Center according to the public data and does not constitute investment opinions or suggestions. If you have any questions, please contact us.
